EUVIMEDEUVIMED entdecken
Crossref

NXP032 Improves Memory Impairment Through Suppression of Tauopathy in PS19 Mice and Attenuates Okadaic Acid-Induced Tauopathy in SH-SY5Y Cells

Hyeyoon Eo, Seong Hye Kim, In Gyoung Ju, Joo Hee Lee, Myung Sook Oh, Youn-Jung Kim

Journal of Neuroimmune Pharmacology · 2025

DOI: 10.1007/s11481-025-10175-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroimmune Pharmacology, 2025. Verfasst von Hyeyoon Eo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul, 02447, Republic of Korea. Hauptthemen laut MEDLINE: Tauopathies, Okadaic Acid, Memory Disorders, Ascorbic Acid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Research Foundation of Korea, the BK21 FOUR program of National Research Foundation of Korea, Nexmos.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tauopathy is widely observed in multiple neurodegenerative diseases such as Alzheimer's disease (AD) and characterized by abnormal tau protein phosphorylation, aggregation and its accumulation as a form of neurofibrillary tangle (NFT) in the brain. However, there are no effective treatments targeting tau pathology in the AD. Vitamin C is known to reduce tauopathy and modulate one of its regulators called glycogen synthase kinase 3 (GSK3) in the body. Nevertheless, vitamin C has a limitation of its stability during metabolism due to its chemical properties. Thus, in the current study, NXP032 (a vitamin C/aptamer complex) was tested as a candidate for tau-targeting treatment because it can preserve antioxidative efficacy of vitamin C before it can reach the target tissue. In this context, the current study aimed to investigate the therapeutic effect of NXP032 on tauopathy in vivo and in vitro. As a result, NXP032 attenuated cognitive and memory decline and reduced NFT and tau hyperphosphorylation in the P301S mutant human tau transgenic mice (or called PS19 mice). In addition, NXP032 suppressed neuroinflammation found in the PS19 mice. Furthermore, NXP032 protected SH-SY5Y human neuroblastoma cells from okadaic acid (OKA)-induced cytotoxicity. Especially, 10 ng/ml of NXP032 reduced tau hyperphosphorylation and GSK3 activation though its phosphorylation at Tyr216 site which were promoted by OKA treatment in the SH-SY5Y cells. Taken together, our results suggest that NXP032 might be a potential therapy for AD and tauopathy-related neurodegenerative disorders as well.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TauopathiesOkadaic AcidMemory DisordersAscorbic AcidAnimalsMiceHumansMice, TransgenicCell Line, Tumortau ProteinsMalePhosphorylation

Stichwörter der Autor:innen

AptamerMemory impairmentNXP032Okadaic acidPS19 miceTauopathyVitamin C

Substanzen

Okadaic Acidtau ProteinsAscorbic Acid

Autor:innen und Institutionen

  • Department of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul, 02447, Republic of Korea.
  • Department of Food and Nutrition, Chung-Ang University, Anseong, 17546, Republic of Korea.
  • Department of Oriental Pharmaceutical Science, College of Pharmacy and Kyung Hee East-West Pharmaceutical Research Institute, Kyung Hee University, Seoul, 02447, Republic of Korea.
  • College of Nursing Science, Kyung Hee University, Seoul, 02447, Republic of Korea.
  • Department of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul, 02447, Republic of Korea. msohok@khu.ac.kr.
  • Department of Oriental Pharmaceutical Science, College of Pharmacy and Kyung Hee East-West Pharmaceutical Research Institute, Kyung Hee University, Seoul, 02447, Republic of Korea. msohok@khu.ac.kr.

Förderung

  • National Research Foundation of Korea
  • the BK21 FOUR program of National Research Foundation of Korea
  • Nexmos

Zitieren

APA

Eo, H., Kim, S. H., Ju, I. G., Lee, J. H., Oh, M. S., & Kim, Y. J. (2025). NXP032 Improves Memory Impairment Through Suppression of Tauopathy in PS19 Mice and Attenuates Okadaic Acid-Induced Tauopathy in SH-SY5Y Cells. Journal of Neuroimmune Pharmacology. https://doi.org/10.1007/s11481-025-10175-9

Vancouver

Eo H, Kim SH, Ju IG, Lee JH, Oh MS, Kim YJ. NXP032 Improves Memory Impairment Through Suppression of Tauopathy in PS19 Mice and Attenuates Okadaic Acid-Induced Tauopathy in SH-SY5Y Cells. Journal of Neuroimmune Pharmacology. 2025. doi:10.1007/s11481-025-10175-9

BibTeX
@article{Eo2025,
  author = {Eo, Hyeyoon and Kim, Seong Hye and Ju, In Gyoung and Lee, Joo Hee and Oh, Myung Sook and Kim, Youn-Jung},
  title = {NXP032 Improves Memory Impairment Through Suppression of Tauopathy in PS19 Mice and Attenuates Okadaic Acid-Induced Tauopathy in SH-SY5Y Cells},
  journal = {Journal of Neuroimmune Pharmacology},
  year = {2025},
  doi = {10.1007/s11481-025-10175-9}
}
Kostenlos starten →